Global Downstream Bioprocessing Markets Report, 2017-2018 & Forecast to 2021
DUBLIN, Nov. 5, 2018 /PRNewswire/ --
The "Downstream Bioprocessing Markets (Chromatography Columns and Resins, Membrane Adsorbers, Filtration Systems, Sensors)" report has been added to ResearchAndMarkets.com's offering.
Bioprocessing consists of two major processing steps: upstream and downstream processing. Upstream processing refers to the culturing of cells and microorganisms to create biologically active product for use in research and in the production of biopharmaceuticals. This processing is typically done through cell culture or fermentation. Downstream processing refers to the separation and refinement of bulk bioproduct into a form suitable for its end use.
Chromatography Columns and Resins
The chromatography columns and resins segment of the downstream bioprocessing components market is a large segment. There are many issues driving this segment. The continuous need for new and different column and resin technologies continues to drive growth of this market segment as bioprocessors battle what they say is their biggest downstream bottleneck.
Membrane Adsorbers
Membrane adsorbers are thin, synthetic, porous membranes modified with functional groups similar to those on equivalent resins. Membrane adsorbers are growing in use, finding more deployment in flexible manufacturing facilities in which speed of operations and robust performance are essential production criteria.
Filtration Systems
The filtration segment of the downstream bioprocessing market includes microfiltration, ultrafiltration, nanofiltration, reverse osmosis, and ion-exchange filtration. Filtration is important for harvesting biologic actives from cell media and other downstream separations because biomolecules are highly sensitive to heat and chemicals. The segment is being spurred by the general increase in biodrug products.
Sensors
In a fast-paced production environment, in which the various processing steps must be closely monitored, bioprocessors must implement advanced control technologies. Many are applying novel automation and software systems to monitor and control bioprocessing. On-line technologies that can monitor, control, and improve downstream process steps significantly benefit bioprocessors. They can optimize the quality of their product by harnessing the timely data on critical operational and quality parameters available by implementing on-line monitoring systems, such as sensors. Sensor technology can help the industry better manage key challenges, such as having to comply with new regulations, and address cost control and risk issues during drug development and production.
Market Trends and Drivers, Challenges, and Developments
Even though bioprocessors and others in the industry have been in business for a number of years, they face a number of issues and challenges to their continued success and the development of future therapeutics. Advances in science and technology, as well as new demands from customers, present a continuous flow of issues to be addressed. Bioprocessors must innovate to be able to continue to command premium prices. For them, speed, process innovation, and operational excellence are must-win battles. Market trends and drivers, challenges, and developments are discussed in the report.
The Market Landscape
The report notes that advances in technology and bioprocessing equipment are making it possible to develop quality biologic drugs. This is increasing the use of bioprocessing equipment, which drives the biopharmaceutical market. The growing numbers of elderly, notably those suffering from chronic illnesses, will help generate a continuing need for novel biotherapeutic drugs. And as demand increases, bioprocessors will need processing technologies and components that will facilitate the production of high quality products. As a result, the significance of the downstream bioprocessing market will grow.
Competitive Analysis
The report contains profiles of a wide range of companies. The downstream bioprocessing market players profiled in the report include:
- 3M Company
- Abec
- Alfa Laval
- Avantor Performance Materials
- BIA Separations
- Boehringer Ingelheim Pharmaceuticals
- Bosch
- Dow
- ESI Ultrapure
- Finesse Solutions
- FujiFilm Diosynth biotechnologies
- GE Healthcare Life Sciences
- GEA Germany Dsseldorf
- Lonza Group
- MilliporeSigma
- Natrix Separations
- Nordson Medical
- Pall Biotech
- Parker Hannifin
- Repligen
- Sartorius AG
- Thermo Fisher Scientific
- W. L. Gore & Associates, Inc.
- Watson-Marlow Fluid Technology Group
For more information about this report visit https://www.researchandmarkets.com/research/472n4x/global_downstream?w=5
Did you know that we also offer Custom Research? Visit our Custom Research page to learn more and schedule a meeting with our Custom Research Manager.
Media Contact:
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets
Share this article